These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28137212)

  • 1. Diagnosis and Treatment of Dyslipidaemias in Athletes.
    Christou GA; Kouidi EJ; Deligiannis AP; Kiortsis DN
    Curr Vasc Pharmacol; 2017; 15(3):238-247. PubMed ID: 28137212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.
    ; ;
    Atherosclerosis; 2019 Nov; 290():140-205. PubMed ID: 31591002
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects.
    Filippatos TD; Liontos A; Christopoulou EC; Elisaf MS
    Curr Vasc Pharmacol; 2019; 17(4):332-340. PubMed ID: 29424317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996-2007.
    Ferrières J; Bongard V; Dallongeville J; Arveiler D; Cottel D; Haas B; Wagner A; Amouyel P; Ruidavets JB
    Arch Cardiovasc Dis; 2009 Apr; 102(4):293-301. PubMed ID: 19427606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidaemias in 2017: Atherogenic lipoproteins as treatment targets.
    Catapano AL
    Nat Rev Cardiol; 2018 Jan; 15(2):75-76. PubMed ID: 29336436
    [No Abstract]   [Full Text] [Related]  

  • 6. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
    Reiner Z
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917
    [No Abstract]   [Full Text] [Related]  

  • 7. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.
    Shapiro MD; Fazio S
    Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglycerides and risk of atherosclerotic cardiovascular disease: An update.
    Farnier M; Zeller M; Masson D; Cottin Y
    Arch Cardiovasc Dis; 2021 Feb; 114(2):132-139. PubMed ID: 33546998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2018 Guidelines for the management of dyslipidemia.
    Rhee EJ; Kim HC; Kim JH; Lee EY; Kim BJ; Kim EM; Song Y; Lim JH; Kim HJ; Choi S; Moon MK; Na JO; Park KY; Oh MS; Han SY; Noh J; Yi KH; Lee SH; Hong SC; Jeong IK
    Korean J Intern Med; 2019 Jul; 34(4):723-771. PubMed ID: 31272142
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of the non-fasting lipid profile for lipid-lowering therapy in clinical practice - point of view.
    de Vries M; Klop B; Castro Cabezas M
    Atherosclerosis; 2014 Jun; 234(2):473-5. PubMed ID: 24814412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID).
    Conte C; Maggiore U; Cappelli G; Ietto G; Lai Q; Salis P; Marchetti P; Piemonti L; Secchi A; Capocasale E; Caldara R
    Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1427-1441. PubMed ID: 32605884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ECS guidelines 2016 - dyslipidaemias].
    Sinning D; Landmesser U
    Herz; 2016 Dec; 41(8):671-676. PubMed ID: 27844136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical controversies in lipid management.
    Tziomalos K
    Panminerva Med; 2015 Jun; 57(2):65-70. PubMed ID: 25669164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.
    Musunuru K; Kathiresan S
    Circ Res; 2016 Feb; 118(4):579-85. PubMed ID: 26892959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized Therapy.
    Brown WV
    Clin Pharmacol Ther; 2018 Aug; 104(2):269-281. PubMed ID: 29998536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of dyslipidaemias -  present and future. Guidelines of the Angiology Section of the Slovak Medical Chamber (2013)].
    Gavornik P; Dukát A; Gašpar L;
    Vnitr Lek; 2013 Oct; 59(10):932-8. PubMed ID: 24164369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on therapy with traditional Chinese medicine: An efficacious approach for lipid metabolism disorders.
    Zhang Y; Kishi H; Kobayashi S
    Pharmacol Res; 2018 Aug; 134():200-211. PubMed ID: 29935947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of dyslipidaemias.
    Paramsothy P; Knopp R
    Heart; 2006 Oct; 92(10):1529-34. PubMed ID: 16973811
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.
    Laforest L; Souchet T; Moulin P; Ritleng C; Desamericq G; Le Jeunne P; Schwalm MS; Van Ganse E
    Arch Cardiovasc Dis; 2009 Jan; 102(1):43-50. PubMed ID: 19233108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.